chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccine on the specified date, had a mild reaction of rash/hives around the left arm injection site and on abdomen. Clinic gave me antihistamines for the day  and it cleared up within 24 hours.  The specific issue at hand is about 3-4 days after the injection I begin having some hearing loss in my left ear.  As of this date it has not improved.
lost strenght in her legs and everything; suddenly has some tinglings; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (lost strenght in her legs and everything) and PARAESTHESIA (suddenly has some tinglings) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (lost strenght in her legs and everything) and PARAESTHESIA (suddenly has some tinglings). At the time of the report, ASTHENIA (lost strenght in her legs and everything) and PARAESTHESIA (suddenly has some tinglings) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and no treatment medications were reported.
Vaccine administered 11:24 am  on 1/6/2021. At approximately 11:30-11:31 patient notified this nurse that she "felt funny" and felt as if "my jaw is tightening" also that "my throat is tightening".  Emergency protocol initiated: epipen administered x1dose to left thigh at 11:33am, EMS dispatched via 911, vital signs obtained. VS reported to EMS upon arrival at 11:37am. EMS assumed care of patient after report given and patient was transported to hospital at approximately 11:40 am.
This was the second Moderna Vaccine I received.  I was sick for 2 days after my lst vaccine.  I was not questioned about reactions when I went to get my 2nd shot.  I volunteered the information and it was ignored. With my second vaccine my tongue swelled up that evening.  It affected my speech but not my breathing.  For 7 days I was sick at my stomach,  loss of appetite, low energy and at times became short of breath and felt faint.
Patient was administered on 03/13/2023 reconstituted ActHIB with an expiration date of 03/05/2023.  No current reactions.  Manufacture (Sanofi Pasteur) contacted for guidance.  ActHIB  is a non-live virus which should not be counted as a valid dose per CDC guidelines.  Patient may be revaccinated as soon as possible with no wait period. Patient's mother notified and made aware of vaccination error and manfacture recommendations.  Request to wait on repeat vaccine at this time due to child feeling under the weather from vaccines received yesterday so she  will wait a week or so.  Will followup with mother in 48hours, to maintain no adverse reactions and schedule followup appointment
covid-19; covid-19; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 72-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history was not reported. The patient took concomitant medications. Other medications in two weeks was reported as yes. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of covid-19. Therapeutic measures included Anti-viral details: Product: Covid-19 treatment, Brand: Paxlovid, Treatment started on 18Jul2022 and stopped on 22Jul2022, Administrator route: Oral, Indication: Treatment of COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between the events and suspect drug BNT162B2 cannot be excluded.
Plaintiffs alleges that as a result of immun on 28AUG89, child developed pain, fever, somnolence, irritability & sz.
This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unspecified date, the patient was vaccinated with a dose of improperly stored GARDASIL 9 injection (lot # L037554, expiration date: 25-DEC-2017; dose and route of administration were not reported). No adverse effects were reported. It was stated that vaccination with GARDASIL 9 was not discontinued. There was no product quality complaint (PQC) involved. This is one of the several reports received from the reporter. Additional information has been requested.
1) 911 - On 5/27/2021 at about 7:00pm I started to experience bad chest pain which only increased to severe.   At 2:00pm I contacted a triage nurse associated with the Hospital,  who informed me to hang up and immediately call 911.  I did call 911 and paramedics & ambulance arrived.   I was given EKG, Nitroglycerine, etc. and transported to the ER department.  I was treated by the Dr.  Many lab tests were performed including 2 Troponin tests during the course of my stay.   A CT scan was done as well.    I was told I had chest wall swelling, was treated and released at 5:30am on 5/28/2021. 2)  On 6/12/2021 Experienced a large black & blue spot approx 2" x 6" in the left arm at the original injection site.   Injection site was small hard lump at the onset. 3)  Have been experiencing nose bleeds. (which I have never had before). Note:  I have always been extremely healthy and these symptoms are extremely unusual.   Have had nothing like this prior to my vaccine.    I have had other vaccines in the past with uterly no reactions.....Thank you....
Getting dizzy when he turns his head; Developed red bumps like hives all over his body; Itching all over; Tiredness; Brain fog\ Cloudy brain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog\ Cloudy brain), DIZZINESS (Getting dizzy when he turns his head), URTICARIA (Developed red bumps like hives all over his body), PRURITUS (Itching all over) and FATIGUE (Tiredness) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 005C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced FEELING ABNORMAL (Brain fog\ Cloudy brain) and FATIGUE (Tiredness). On an unknown date, the patient experienced DIZZINESS (Getting dizzy when he turns his head), URTICARIA (Developed red bumps like hives all over his body) and PRURITUS (Itching all over). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Brain fog\ Cloudy brain), DIZZINESS (Getting dizzy when he turns his head), URTICARIA (Developed red bumps like hives all over his body), PRURITUS (Itching all over) and FATIGUE (Tiredness) outcome was unknown.            No concomitant medication was provided by the reporter.   This case was linked to MOD-2021-231649 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non significant follow up received on 19-JUL-2021. Reporter is asking to call on her number.
Initial report received from a report on 07-Oct-2013. A 1-month-old patient (gender unknown) had received PENTACEL vaccine (batch number: unknown, dose number and site of administration not reported) on an unknown date. The patient's medical history was unknown. The patient had no illness at the time of vaccination and concomitant medications. PENTACEL vaccine was administered to 1 month old neonate. No laboratory tests were performed and corrective treatments were not reported. List of documents held by sender: None.
The shot was administered too high on my arm. Next day I could barely move arm. Developed frozen shoulder. Feb 2016 had surgery to release frozen shoulder. Oct 2017 had surgery to remove diseased synovium. I had developed synovitis from flu shot injury. Surgeon also had to remove 4 inches of inflamed tendons that had attached itself to my bicep.
Arm pain, runny nose, fever, muscle aches, headache. Second dose symptoms were less severe than first dose. He had a severe headache after the second dose but not the first. All symptoms resolved within 24 hours, however first dose symptoms lasted longer than the first dose. He had a more severe reaction and longer duration to the first dose than he did the second dose.
Pt received flu shot on 10/10/07, dev. nausea, vomiting and dizziness that day. Developed Bell's palsy on 10-13-07 as diagnosed by doctor. Pt no longer has N/V and getting PT for the B. Palsy per daughter who reported this event.11/6/07-records received for DOS 10/15/07-C/O not feeling well for 5 days, received flu vaccine on Wednesday and on Saturday started getting nauseated, mouth started drooping to right, speech is fairly clear. Some pain bilaterally in right ear. No problem with gait. PE: mouth drooping to right, right eyelid is weak especially upper eyelid. Furrow in the brow causes lower skin lines on right compared with left. EOM normal. Face sensation normal. Abdomen slightly tender to palpation. Impression: Bell's Palsy right, speech appears intact. Gastritis.
Positive COVID test.; Positive COVID test.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from regulatory authority.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 16Dec2021 (Lot number: FL3197) at the age of 59 years as dose 3 (booster), single, intramuscular, administration date 16Apr2021 (Lot number: EP6955) as dose 2, single and intramuscular, administration date 26Mar2021 (Lot number: EP6955) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 18Jan2022, outcome "not recovered" and all described as "Positive COVID test.". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Jan2022) positive, notes: Nasal Swab; (17Jan2022) negative, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Right thigh was red & swollen with some oozing coming from area between both shots.  Redness was approx.   14-16 cm X 14 cm. Child given BENADRYL & BACTROBAN ointment.
36 plus hours of arm pain, bad headache, joint pain, muscle pain, lethargy, unable to sleep, just felt awful! My husband got his shot at the same time and he had the same symptoms except his arm hurt way more than mine. Note that our first SHINGRIX shots did not produce this severe reaction, just some mild soreness in the injection arm.
BRAIN BLOOD CLOTS; This spontaneous report received via social media from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company does not perform follow-up in this scenario to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced brain blood clots. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of brain blood clots was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210504075.; Sender's Comments: V0. 20210505140-COVID-19 VACCINE AD26.COV2.S-Brain blood clot. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Starting not feeling well. Felt very warm, thick saliva (kind that you get right before going to throw up). Nauseous, did not vomit but dry heaved. Lightheaded. Fever. Fast heart beat.
Monovalent booster vaccine given on 09/01/2022. No adverse reaction observed or reported.
1 1/2 wks p/vax diarrhea 4 stools q day; saw gastroenteologist; MD rxed Donnatal-Lomotil;
Covid breakthrough infection. 2/24/2022 including high fever, runny/stuffy nose, cough, all moderate.
Pt was admitted from the ED with acute respiratory failure on 4/14/21, after receiving the vaccine on 4/12/21
Patient experienced flu-like symptoms (no fever) and mild pain at injection site for a few days. On 7/11/19 and 7/12/19, while working as a bus driver, he handled a large amount of luggage. Handling and lifting luggage is not a usual part of his work. The flu-like symptoms and pain intensified then stopped over the weekend. On 7/17/19 while driving his bus, the pain returned in his shoulder blade. On 7/20/19 while driving again, the pain in his shoulder blade intensified and has continued off and on since.
floaters in left eye; Flashing lights; This case was reported by a consumer via call center representative and described the occurrence of eye floaters in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th September 2019 12:00, the patient received the 1st dose of Shingrix. On 13th September 2019, 5 hrs 30 min after receiving Shingrix, the patient experienced flashing lights. On 13th September 2019 05:30, the patient experienced eye floaters. On an unknown date, the outcome of the eye floaters and flashing lights were not recovered/not resolved.   It was unknown if the reporter considered the eye floaters and flashing lights to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. The patient currently saw black floaters in her left eye. The patient consent to follow up.
Chills, body aches, and fever started at 9pm and got worse over the next 3 hours; Fever rose to 102 degrees F by midnight then fell to 100.6 degrees by 7am on 5/5/21; Trouble sleeping from midnight to 7am; Headache, fatigue, body aches, and fever of 100 degrees from 7am until 7pm on 5/5/21; Symptoms subsided around 10pm and were totally gone by the next morning
This case meets vaccine breakthrough criteria .  SXS FEVER, CHILLS, COUGH, MALAISE, N/V/D
Diarrhea; Headache; Dizzy; No appetite; Nausea; Fatigue; A spontaneous report was received from a Consumer concerning a 74-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache, nausea, dizziness, diarrhea, decreased appetite and fatigue.  The patient's medical history was not provided. Concomitant medications reported cholesterol.  On 25-Jan-2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 041L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced headache, nausea, dizziness, diarrhea, decreased appetite and fatigue.  Treatment details included, Tylenol, Imodium.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events were not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt recv vax MAR97 & 25MAY97 pt became pregnant (LMP 15MAY97);pt was tested for varicella antibodies & found to be seronegative;noted that pt did not have any rxn to the vax;
Patient developed a rash on both feet within 10 minutes of vaccine administration. Rash resolved 10 minutes later.
Caller stated on 12/18/20 and on 12/19/20  she had some arm pain and nasal drainage. Caller stated that she went to doctor on 12/21/20  and was diagnosis with Cellulitis and was prescribed steroids and cefalexin for 7days x three times daily. Caller stated that physician does not recommend second injection. Vaers report completed over the phone.
not feeling t; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (not feeling t) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (not feeling t). At the time of the report, VACCINATION COMPLICATION (not feeling t) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications and treatment medications was reported.
Passed out about 5 minutes after receiving the shot. Was sitting in a chair and collapsed to the ground. She regained consciousness within 30 seconds and was sitting in a chair again 5 minutes later
It was reported that a pt received a Fluzone SV 2000-2001 vaccination on 10/31/2000. Reportedly 24 hours after injection the pt developed a local reaction. Four days later developed itching at injection site. Further information is requested. From additional correspondence received on 02/07/2001, it was reported that the pt recovered from this experience. Additional pt, vaccine administrator and responsible physician information was also provided.
This solicited report was received from a consumer (patient's friend) regarding a 58 year old female patient, as part of a market research program by Research Group. The patient's concurrent conditions, medical history and concomitant medications have not been reported.  On an unknown date (also reported as 2 years ago), the patient was vaccinated with a dose of ZOSTAVAX injection (lot#, expiration date, dose and route of administration were not reported) for shingles prophylaxis. On an unknown date (also reported as on the day of vaccine, in the evening), it was reported that the patient's arm blew up and she had to go to the emergency room. The outcome of the event was reported as recovered on an unspecified date (also reported as 2-3 days from the time of injection). The action taken with ZOSTAVAX was reported as not applicable. The reporter considered the event to be related to ZOSTAVAX. Additional information is not expected as the consent to contact the physician was not given.
burning sensation of the skin; flu symptoms; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (burning sensation of the skin), INFLUENZA (flu symptoms) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced SKIN BURNING SENSATION (burning sensation of the skin), INFLUENZA (flu symptoms) and CHILLS (Chills). At the time of the report, SKIN BURNING SENSATION (burning sensation of the skin), INFLUENZA (flu symptoms) and CHILLS (Chills) outcome was unknown.            Concomitant product use was unknown by the reporter. Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-028409 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-028409:1ST Dose case
Patient presented to the pharmacy with complaints of erythema and tenderness at the injection site. Patient's arm has a swollen nodule about 1-2 inches in diameter that she says has gotten worse from day 1. She has tried to scratch at the site due to some itching but then feels pain. She confirmed that she had not taken any medication to help relieve her symptoms since receiving her vaccination.  She also confirmed she has not had any symptoms of hives/rash, difficulty breathing, swelling in the face or throat, or immobility of her arm.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/28/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
On 4/15 and 4/16 baby was cranky and crying, no fever. On 4/18/09 "baby's eyes started rolling back" one time.  On 4/20/09 "everytime MOB put baby down mother noticed baby's eyes rolling back and entire body gets stiff for a few second (5-6 seconds)  Last episode at 0200. Seen in clinic this am by Dr., no seizure activity noted.  Voiding and stooling well, no seizures in family.  Advised to RTC if problems and caution/review with future immunizations.
SWOLLEN LYMPH NODE; BODY ACHES; HEADACHE; FATIGUE; NAUSEA; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced swollen lymph node. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced fatigue. On 09-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, body aches, fatigue, nausea, and swollen lymph node. This report was non-serious.
15Apr 11:30pm: chills, fever 16Apr 8am: body aches, headache (chills continue) 16Apr 11:30am: arm tenderness, headache continues but other symptoms subside 16Apr 8pm: body aches, slight fever; headache subsides 17Apr: 7am other symptoms subside; noted a red, raised area at injection site. 2.5inches wide, 1.5 inches tall, irregular borders. Soreness under the armpit at the lymph node area, no noticeable swelling in that area.
Chills, fever 99.3 and headache from 8am-6pm the day following vaccination, on 2/12/21.